ACA
GBT

Avoro Capital Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Avoro Capital Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000,000
Closed -$48.5M – 37
2019
Q3 		$48.5M Buy
1,000,000
+50,000
+5% +$2.61M 2.02% 17
2019
Q2 		$50M Hold
950,000
– – 1.73% 16
2019
Q1 		$50.3M Buy
950,000
+600,000
+171% +$29.5M 2.17% 14
2018
Q4 		$14.4M Buy
350,000
+62,500
+22% +$2.34M 0.86% 22
2018
Q3 		$10.9M Sell
287,500
-413,048
-59% -$18.3M 0.5% 29
2018
Q2 		$31.7M Sell
700,548
-1,065,000
-60% -$48.5M 1.22% 25
2018
Q1 		$85.3M Sell
1,765,548
-76,348
-4% -$4.26M 4.07% 7
2017
Q4 		$72.5M Buy
1,841,896
+717,596
+64% +$26.8M 4.7% 6
2017
Q3 		$34.9M Buy
1,124,300
+264,300
+31% +$7.43M 2.71% 15
2017
Q2 		$23.5M Buy
860,000
+45,000
+6% +$1.34M 2.97% 12
2017
Q1 		$30M Sell
815,000
-180,838
-18% -$4.55M 3.84% 10
2016
Q4 		$14.4M Buy
995,838
+126,575
+15% +$2.22M 2.91% 16
2016
Q3 		$20M Sell
869,263
-94,383
-10% -$1.8M 3.52% 12
2016
Q2 		$16M Buy
963,646
+755,560
+363% +$15.2M 3.55% 12
2016
Q1 		$3.3M Buy
+208,086
New +$3.7M 1.15% 24

Other funds holding GBT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Avoro Capital Advisors's GBT Position: Q4 2019 in Review

Avoro Capital Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2019, closing a stake of 1,000,000 shares — an estimated $48.5M sold.

Avoro Capital Advisors first reported a position in GBT in Q1 2016 and held it in 15 quarters. The position peaked at $85.3M in Q1 2018. 234 funds tracked by Wall St. Rank hold GBT as of Q4 2019.

  • Avoro Capital Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Avoro Capital Advisors sold 1,000,000 Global Blood Therapeutics, Inc. shares in Q4 2019, an estimated $48.5M.
  • Avoro Capital Advisors first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 15 quarters.
  • Avoro Capital Advisors's Global Blood Therapeutics, Inc. position peaked at $85.3M in Q1 2018.
  • 234 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2019.

Based on Avoro Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.